1. Pink Sheet

US FDA Announces Plans To Resume Domestic Inspections

 
• By Joanne S. Eglovitch

Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.

As state governments begin to rescind stay-at-home orders, the United States begins to re-open service and retail businesses.
fda investigators to venture out again domestically, where safe • Source: Shutterstock

After a four-month lapse, the US Food and Drug Administration announced plans to resume ‘prioritized’ domestic good manufacturing practice inspections on 20 July, focusing on states and localities that have low rates of COVID-19 infections.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance